In conclusion, transforming immunologically "cold" tumors into "hot" counterparts represents a pivotal advancement in fully realizing the capabilities of immunotherapy for cancer treatment.

This innovative strategy, aimed at addressing the challenges posed by camouflage, coercion and cytoprotecion, requires a comprehensive approach that combines advancement in molecular insights, biomaterials, epigenetic modifications, metabolic strategies, neural-immune interactions and microbiome engineering.
They lost me at Quantum dots.

Leronlimab should help to avoid the use of copper and polymers being introduced as Trojan horses.